Guardian Asset Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Sell
3,207
-88
-3% -$89.9K 1.77% 13
2026
Q1
$3.03M Sell
3,295
-103
-3% -$104K 1.77% 15
2025
Q4
$3.65M Sell
3,398
-39
-1% -$37.3K 1.9% 13
2025
Q3
$2.62M Sell
3,437
-79
-2% -$58.8K 1.41% 16
2025
Q2
$2.74M Buy
3,516
+43
+1% +$33.4K 1.58% 14
2025
Q1
$2.87M Buy
3,473
+75
+2% +$62.4K 1.87% 13
2024
Q4
$2.62M Sell
3,398
-25
-0.7% -$20.7K 1.68% 13
2024
Q3
$3.03M Buy
3,423
+56
+2% +$50.3K 2.06% 11
2024
Q2
$3.05M Sell
3,367
-48
-1% -$38.4K 2.24% 12
2024
Q1
$2.66M Buy
3,415
+91
+3% +$64.8K 2.2% 12
2023
Q4
$1.94M Buy
+3,324
New +$1.94M 1.82% 12

Other funds holding LLY

Guardian Asset Advisors's LLY Position: Q2 2026 in Review

Guardian Asset Advisors reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $89.9K and leaving 3,207 shares worth $3.85M. The position accounts for 1.77% of the portfolio, ranked #13.

Guardian Asset Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,651 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Guardian Asset Advisors held 3,207 shares of Eli Lilly worth $3.85M as of Q2 2026.
  • Guardian Asset Advisors sold 88 Eli Lilly shares in Q2 2026, an estimated $89.9K.
  • Eli Lilly made up 1.77% of Guardian Asset Advisors's portfolio in Q2 2026, its #13 holding.
  • Guardian Asset Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,651 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Guardian Asset Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.